Money Is Moving

Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Inwentash buying at Avicanna (T:AVCN)

Updated Monday Feb 22, 2021 06:06 AM EDT

Sheldon Inwentash, a 10% Holder, acquired 25,800 Common Shares on a direct ownership basis at prices ranging from $1.480 to $1.500 between February 10th, and 16th, 2021. The insider also acquired 61,400 Common Shares on a control or direction basis for registered holder ThreeD Capital at prices ranging from $1.412 to $1.444 between February 11th and 16th, 2021. This represents a $126,341 investment into the company's shares and an account share holdings change of 3.9%.

Avicanna is in the Biotechnology & Medical Research Sub Industry Group under the Healthcare Sector.

Avicanna Inc. is a Canada-based biopharmaceutical company. The Company is focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. In addition to its developing pharmaceutical pipeline, it has product lines, including Pura H&W and RHO Phyto. Pura H&W is a line of cannabidiol (CBD) consumer derma-cosmetic products. RHO Phyto is a line of medical cannabis products containing varying ratios of CBD and tetrahydrocannabinol (THC). The Company's subsidiary includes Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S.

INK Edge Outlook

CONDITIONS:
Latest
6 months ago
1 year ago
Overall
Mixed
Cloudy
Mixed
The INK Edge Outlook is a quantitative process that ranks a stock based on our V.I.P. criteria.
View outlooks on all Canadian listed stocks at inkresearch.com.
Two-week free trial for first time users.
Go to Avicanna Inc. (AVCN)'s company page

Comment On!

140
Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to CanadianInsider.com (via Easy Blurb).

Comment On!

No Comments

Twitter

Search (past week) for $AVCN.CA

  • No tweets found

Stocktwits